US5078999A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating systemic lupus erythematosus
Assignee: Wyeth LLC
•
Filing: 1991-02-22
•
Granted: 1992-01-07
•
Expires: 2011-02-22
Abstract
Abstract This invention provides a method of treating systemic lupus erythematosus in a mammal in need thereof which comprises administering an effective amount of rapamycin orally, parenterally, intranasally, intrabronchially, or rectally.
Inventors
- 👤 Linda M. Warner
- 👤 Laurel M. Adams
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:33
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/66; A61K35/74; A61K31/00; A61K31/70; A61K31/33; A61K31/395; A61K31/435; A61K31/44
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
40 words
A method of arresting the development or retarding the progression of systemic lupus erythematosus in a mammal in need thereof which comprises administering to said mammal a lupus arresting or retarding amount of rapamycin orally, parenterally, intranasally, intrabronchially, or rectally.
Claim 2
Independent Claim
40 words
A method of arresting the development or retarding the progression of systemic lupus erythematosus in a mammal in need thereof which comprises administering to said mammal a lupus arresting or retarding amount of rapamycin orally, parenterally, intranasally, intrabronchially, or rectally.
Claim 3
Dependent Claim
19 words
The method of claim 1, which comprises administering rapamycin orally in a daily dose of 0.01 to 75 mg/kg.
Claim 4
Dependent Claim
19 words
The method of claim 1, which comprises administering rapamycin orally in a daily dose of 0.1 to 50 mg/kg.
Claim 5
Dependent Claim
21 words
The method of according to claim 1, which comprises administering rapamycin orally in a daily dose of 1 to 50 mg/kg.
Claim 6
Dependent Claim
20 words
The method according to claim 1, which comprises administering rapamycin parenterally in a daily dose of 0.01 to 50 mg/kg.
Claim 7
Dependent Claim
20 words
The method according to claim 1, which comprises administering rapamycin parenterally in a daily dose of 0.1 to 10 mg/kg.
Claim 8
Dependent Claim
20 words
The method according to claim 1, which comprises administering rapamycin parenterally in a daily dose of 0.1 to 1 mg/kg.
References Cited (Backward Citations)
US3929992A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-01-06 | 1995-07-08 | 1996-01-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-01-06 | 1999-07-08 | 2000-01-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-01-06 | 2003-07-08 | 2004-01-07 | $7700.00 | Window Closed / Lapsed |